Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untreated Acute Myeloid Leukemia: BRIGHT AML 1019 Phase III TrialsJörge E. Cortes, Mikkael A. Sekeres, Akil Merchant et al.|Future Oncology|2019Cited by 48